Mary J. Ortner

Mary is a molecular pharmacologist with 25 years industry experience in pharmaceuticals, biotechnology, and consulting. She was a research scientist at NIH (Environmental Biophysics) for six years before joining Boehringer Ingelheim Pharmaceuticals, Inc., where she worked in R&D and clinical research. She then co-founded MicroSource Discovery Systems, Inc. and served six years as its CEO. Mary was later Sr. Director of External Development at Shire Biologics and Director of Business Development at Inpharmatica, Ltd. She also helped establish the consulting group, BioXcel Corporation, as SVP, Business Development and Alliances. Mary holds a PhD from the University of Hawaii, an MS from the California State University, Los Angeles, and an MBA from the University of Connecticut.